Impiricus

Private

Atlanta, GeorgiaHealthcare & Life Scienceshttps://impiricus.com/

Last Round

Seed

Apr 26, 2022

Est. Valuation

$5.5M

Total Funding Raised

$3.49M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Impiricus is a healthcare technology company that provides an AI-powered engagement platform to ethically connect physicians with pharmaceutical company resources.

Sector

Healthcare & Life Sciences

Verticals

NLP & Conversational AI, Enterprise Communication, Patient Engagement

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Data as a Service

AI Layer

Application

Keywords

HCP engagementhealthcare professional engagementpharma marketingAI engagement enginelife sciences softwareenterprise SaaSpharma techconversational AIdata as a serviceDaaShealthcare data analyticsAI agentic platformpharma sales enablementhealthcare communication platformmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Impiricus Comps

Public and private peers based on sector, stage, and business model.

Impiricus comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Impiricus Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Apr 26, 2022
Pre Seed	Apr 2, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Sandy Donaldson

Co-Founder, President Chief Strategy Officer

Founding Team

Or Maoz

Chief Technology Officer

Executive Team

Steve Miller

Chief Financial Officer

Executive Team

Shuo Jiang

Chief Operating Officer

Executive Team

View all key people

Impiricus Investors

Notable investors and investment history

Impiricus investors
Investor	Rounds
Atlanta Tech Village	Pre Seed
Surface Ventures	Seed
FCA Venture Partners	Seed
Johnson Venture Partners	Pre Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Dec 27, 2025
Added GlaxoSmithKline as a customer in the pharmaceutical industry.
Dec 27, 2025
Added NovoPact, a biotechnology startup, as a customer.

View all signals

Impiricus Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Impiricus Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Impiricus's valuation, stock price, and market status.

Firmographic Details

HeadquartersAtlanta, Georgia

Employee Range184

Year Founded2020

Last FundingApr 26, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.